Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Clinical trial NCT00150046 · COMPLETED

Trial details

NCT number: NCT00150046
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Transplantation

Start date: 2004-12-01
Primary completion: 2007-05-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.